Works matching IS 03065251 AND DT 2019 AND VI 85 AND IP 2


Results: 20
    1

    Issue highlights.

    Published in:
    British Journal of Clinical Pharmacology, 2019, v. 85, n. 2, p. 283, doi. 10.1111/bcp.13854
    Publication type:
    Article
    2
    3
    4
    5
    6

    Obesity‐induced CYP2E1 activity in children.

    Published in:
    2019
    By:
    • Gade, Christina;
    • Dalhoff, Kim;
    • Petersen, Tonny;
    • Riis, Troels;
    • Christensen, Hanne Rolighed;
    • Holst, Helle;
    • Schmeltz, Camilla;
    • Holm, Jens Christian;
    • Chabanova, Elizaveta;
    • Mikus, Gerd;
    • Burhenne, Juergen
    Publication type:
    Letter to the Editor
    7
    8
    9

    Thrombotic microangiopathy associated with gemcitabine use: Presentation and outcome in a national French retrospective cohort.

    Published in:
    British Journal of Clinical Pharmacology, 2019, v. 85, n. 2, p. 403, doi. 10.1111/bcp.13808
    By:
    • Daviet, Florence;
    • Moussi‐Francès, Julie;
    • Sallée, Marion;
    • Burtey, Stéphane;
    • Jourde‐Chiche, Noémie;
    • Pourroy, Bertrand;
    • Grandvuillemin, Aurélie;
    • Grange, Steven;
    • Frémeaux‐Bacchi, Véronique;
    • Coppo, Paul;
    • Rouby, Franck;
    • Micallef, Joëlle;
    • Poullin, Pascale;
    • Mancini, Julien;
    • Duffaud, Florence;
    • Sabatier, Renaud
    Publication type:
    Article
    10
    11
    12
    13
    14
    15

    The Developing Regorafenib Eye drops for neovascular Age‐related Macular degeneration (DREAM) study: an open‐label phase II trial.

    Published in:
    British Journal of Clinical Pharmacology, 2019, v. 85, n. 2, p. 347, doi. 10.1111/bcp.13794
    By:
    • Joussen, Antonia M.;
    • Zeitz, Oliver;
    • Wolf, Sebastian;
    • Kaiser, Peter K.;
    • Boyer, David;
    • Schmelter, Thomas;
    • Deeg, Gesa;
    • Richter, Annett;
    • Zimmermann, Torsten;
    • Hoechel, Joachim;
    • Buetehorn, Ulf;
    • Schmitt, Walter;
    • Sandbrink, Rupert;
    • Stemper, Brigitte;
    • Boettger, Michael K.
    Publication type:
    Article
    16
    17
    18
    19

    Anti‐IL‐7 receptor α monoclonal antibody (GSK2618960) in healthy subjects – a randomized, double‐blind, placebo‐controlled study.

    Published in:
    British Journal of Clinical Pharmacology, 2019, v. 85, n. 2, p. 304, doi. 10.1111/bcp.13748
    By:
    • Ellis, Joanne;
    • Maurik, Andre;
    • Fortunato, Lea;
    • Brown, Kim;
    • Brett, Sara;
    • Craigen, Jenny L.;
    • Gray, Frank;
    • Thompson, Paul W.;
    • Gisbert, Sophie;
    • Chen, Keguan;
    • Schwartz, Ann;
    • McHugh, Simon;
    • Want, Andrew;
    • Santos Franco, Sara;
    • Oliveira, Joao‐Joaquim;
    • Price, Jeffrey;
    • Davis, Bill;
    • Fernando, Disala;
    • Cheriyan, Joseph;
    • Kousin‐Ezewu, Onajite
    Publication type:
    Article
    20

    Issue Information.

    Published in:
    British Journal of Clinical Pharmacology, 2019, v. 85, n. 2, p. 281, doi. 10.1111/bcp.13676
    Publication type:
    Article